heliosDX

heliosDX is a National Clinical Reference Laboratory in the Health Care industry, upholding patient care with its offerings of High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. Founded in 2015 and headquartered in the United States, the company is contracted in 44 of the lower 48 states and seeks to expand its reach and capabilities. heliosDX distinguishes itself by continuously investing in its infrastructure, employing efficient scientific instruments and cutting-edge software to ensure fast and accurate reporting that meets and exceeds industry benchmarks.

With a focus on patient and client care, heliosDX offers physician-designed panels that assist in testing compliance and reporting education, with the goal of achieving physician and patient satisfaction. While details of the last investment and involved investors are not disclosed, heliosDX's commitment to innovation, alongside its wide geographic coverage and comprehensive testing services, positions it as a compelling potential investment opportunity in the dynamic healthcare sector.